Monica Gandhi MD, MPH Profile picture
May 21, 2021 22 tweets 8 min read Read on X
WHY DID THE CDC RECOMMEND NOT TO TEST ASYMPTOMATIC PEOPLE AFTER VACCINATION (nor to quarantine after exposure if no symptoms) A thread. I start with this piece by my colleague @AmeshAA at Johns Hopkins: how testing algorithms change after vaccination
thehill.com/opinion/health…
Okay, why did we test asymptomatic people at all with COVID-19? Because there is asymptomatic transmission with this virus (see @NEJM paper we wrote early in pandemic below) unlike so many viruses where "syndromic surveillance" (testing if have symptoms)
nejm.org/doi/full/10.10…
works to curb spread. In fact, this is true of the original SARS in 2002-03: because you were infectious when you had symptoms, people could be isolated if they felt unwell & pandemic was quickly curtailed after 8098 cases total (although it caused severe disease like this one) Image
This is also true of influenza which is why I think best way to curtail flu in future winters is to ask people who are sick to stay home (as I said in this @scientificamerican piece. You can wear mask but again, flu is not spread asymptomatically.
scientificamerican.com/article/some-p…
Then, with more careful contact tracing studies, we realized your viral load matters. This study from Spain showed that increasing viral load values in nasopharyngeal swabs of COVID-19 patients were associated with greater risk of transmission
thelancet.com/journals/lanin…
And that asymptomatic patients had much lower viral loads (4-fold) than symptomatic patients which is why they were less likely to transmit. Sadly, we seldom incorporate the "CT" value when telling people the results of their PCR test (given as yes/no) sciencemag.org/news/2020/09/o…
which is of course a huge mistake. "CT" stands for cycle threshold and means the number of times a PCR machine has to cycle before giving you a positive result. A high number of cycles (>30 or so) means the viral load is extremely low & not infectious by other studies.
Okay, so let's now turn our attention to the post-vaccination setting where we - unfortunately- are still doing a lot of swabbing of asymptomatic people after vaccination (often in nursing homes, for example or Yankees). 4 studies show us important finding that viral loads low
in the nose if you are asymptomatic after vaccination. These studies were well done because they actually bothered to measure viral loads via CT values to determine viral loads low. Those studies here:
nature.com/articles/s4159…
medrxiv.org/content/10.110…
academic.oup.com/cid/advance-ar…
I can go through all of them if you want but I found this one the most amazing: The UK performed 1,610,562 PCR tests (with CT values) on 373,402 people as vax rolling out. Vaccines reduced asymptomatic infection (as many studies show) but also took CT >30
medrxiv.org/content/10.110…
Meaning, even if you were asymptomatic & had some virus in your nose, the CT was >30, very low viral loads, can't transmit. And I don't call this a "breakthrough", I call this vaccine success because if you are exposed, all that IgA, IgG and T cells found in your nasal mucosa
from the vaccines rush in to fight the virus as it tries to replicate & stops it from replicating much so the viral load is very low: you have no symptoms and you can't transmit. To remember that these vaccines produce IgA (which is an antibody that protects your mucosal
surfaces like the inner lining of your nose, please see this thread. Also reminds us that IgG (which we know is generated by vaccines) goes happily from bloodstream into nasal mucosa and acts there too:
And what, of course, of our beloved T cells generated by the vaccines so aptly as summarized in previous threads? They get into the nasal mucosa as well, extremely readily, and there to fight the virus if it ever dares come near a vaccinated person.
pubmed.ncbi.nlm.nih.gov/9490657/
So, if you a) have no symptoms after vaccination; b) fight the virus with your nasal immunity if you see it so that viral load remains low & can't transmit, then testing asymptomatic individuals after vax is not only not indicted, but drain on public health resources
In fact- eek- I just paid CA taxes Monday & wondered about public health resources in CA with our high levels of vaccination & low cases and low test positivity rate (0.8% or 8/1000 so we are doing a lot of testing). So CDC right to follow symptomatic breakthroughs
And of course, relevant to this thread are all the many many studies that show us even asymptomatic infection itself (having in your nose) massively reduced by vaccines: hividgm.ucsf.edu/covid-19-vacci… Image
Someone asked me how they can download this table with links: we posted here. I believe asymptomatic testing after vaccination still being done in some hospitals/nursing homes; athletes; schools: above thread gives justification to only do if symptomatic
hividgm.ucsf.edu/covid-19-vacci…
If we continue to do asymptomatic testing after vaccination (not recommended by CDC), looks like we can get into situations like the ones below with athletes not being able to play (or patients not getting procedures or teachers staying out of school etc.)
politifact.com/article/2021/j…
Simple screening algorithm for monitoring if breakthrough happening or not after vaccination- if virus still circulating after vax, you can get it in nose, fight it with your IgA/IgG/T cells and bring it down to low levels- that is vax success not failure so look at CT carefully Image
6/29/21: So, what is happening in UK with delta? Because UK testing asymptomatic after vax, finding "cases" (or successful vax recipients with dead/low level delta virus in nose), hospitalizations not high. Vax "decoupling" link between cases & admissions
reuters.com/world/uk/uk-co…
Article to add to this from @NEJM yesterday showing 81% reduction in infection (even asymptomatic as routine swabs weekly) after 1 dose, 91% after 2 doses and importantly, CT values of PCR tests show lower viral load 40% in vax'd, making harder to transmit
nejm.org/doi/10.1056/NE…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Monica Gandhi MD, MPH

Monica Gandhi MD, MPH Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MonicaGandhi9

Aug 30, 2023
HOW LONG DOES IMMUNITY LAST? To COVID vaccines or infection? We do not really know but there have been some really nice papers lately that give us more information. Please remember immunity divided into antibodies (which can come down & not work as well against variants)
IgA is one in the nose & mouth ("mucosa") that is raised by shots (vaccines) to certain extent but rise higher after natural infection; IgG is the one that is "humoral" or in the bloodstream. Many threads on here about cellular-mediated immunity: B & T cells cover all variants
This recent preprint is really important and summarized by @florian_krammer below in depth. Main take-aways: Breakthrough infections induce IgA (we knew) but protection from vaccine long-lasting even against former variants to severe disease/mortality
Read 8 tweets
May 3, 2023
RSV VACCINE FOR OLDER ADULTS: Respiratory syncytial virus (RSV) respiratory virus (most common after flu pre-COVID). 2 subtypes, A&B (1 dominates/season). Droplet; Recurrent infections. Most severe in neonates & adults >65; FDA approves 1st RSV vax today
msn.com/en-us/news/us/…
RSV vaccine 3 trials of new RSV vaccine, all published in the @NEJM recently so just to keep them straight- here is the vaccine which just got approved May 3 by the FDA for older adults. Remember our T/B cells so protection against severe disease higher!
nejm.org/doi/full/10.10…
A single dose of the RSVPreF3 OA vaccine had an acceptable safety profile and prevented RSV-related severe respiratory illness by 94% in adults>=60 years (71% against RSV infection, likely to fall with time as antibodies fall but severe disease protection will remain)
Read 4 tweets
Mar 21, 2023
NASAL VACCINES: To explain nasal vaccines, we have to explain the immune system first.
IgA is an antibody that helps attack the pathogen and exists in mucosal surfaces (like nose/mouth)
IgG is an antibody that is in the bloodstream
bbc.com/news/world-asi…
Cellular immunity is fantastic, redundant (so even if one cell line down in immunocompromised, have other), generated by either vaccine or infection; Comprised of
T cells- so in breadth from vax - works even across spike protein with its mutations
And the 2nd type of cell produced by vaccines or infection -B cell- amazing thing about B cells is that - if see omicron or one of its subvariants in future- they make antibodies adapted to that variant or subvariant (aided by T cells); adaptive immunity
Read 15 tweets
Mar 15, 2023
PUBLIC HEALTH POLICY: Seem to be at reckoning phase of COVID response- what worked, what didn't. Which interventions will be used in future pandemic responses? Interventions asked of public need good medical evidence for them (e.g. RCTs preferably, systematic reviews) to impose
In our field, Cochrane reviews represent best way to sum up the medical evidence to date by performing meta-analyses or systemic reviews of currently-available data; here is Cochrane on masks & other interventions for respiratory viruses including COVID
cochranelibrary.com/cdsr/doi/10.10…
Many asked past 3 years how CDC developed policies on masks (& age to mask), distancing (feet), ventilation, schools-> all non-pharmaceutical interventions. Originally theory-based. Now 3 years in, have data (RCTs highest level) to form policies from both US and other countries
Read 4 tweets
Mar 6, 2023
VACCINE DISCRIMINATION: We need to stop vaccine requirements for US entry like almost every other country. Am finishing COVID chapter for our ID "bible" & vaccines prevented transmission early on with alpha, but not enough now with current variants to justify such discrimination
Moreover, shame, stigma, blame (remember COVIDiots?), coercion, discrimination not good public health tools. When used for HIV, public health & ID physicians decried them but tactics used a lot in COVID. This book tries to explore & correct that for future
barnesandnoble.com/w/endemic-moni…
Concept of #harmreduction in pandemic responses means watching carefully if vulnerable people (like students, older people, low-income populations, migrants, sex workers, prisoners, those with disabilities, refugees, minorities) harmed more by response
nature.com/articles/s4146…
Read 4 tweets
Feb 8, 2023
FEAR: Some media & public health officials concerned Americans aren't fearful of COVID now. But the vaccines & therapeutics DO WORK. If we can't celebrate biomedical advances & imbibe their effectiveness (we have better tools for COVID than flu), what is point of developing?
In HIV medicine, when therapies came out, we didn't say to people- stay fearful; make this the controlling principle of your life. The book #Endemic I wrote (coming out July 11, 2023) hails these biomedical advances & the age we are in to fight pandemics to reassure the world
This is a rather brilliant summary of the issue from @benryanwriter
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(